American Society of Hematology 2020 guidelines for sickle cell disease: Prevention, diagnosis, and treatment of cerebrovascular disease in children and adults

Authors

M.R. DeBaun, Vanderbilt University
L.C. Jordan, Vanderbilt University
A.A. King, Washington University School of Medicine in St. Louis
J. Schatz, University of South Carolina
E. Vichinsky, Children's Hospital Oakland Research Institute
C.K. Fox, University of California, San Francisco
R.C. McKinstry, Washington University School of Medicine in St. Louis
P. Telfer, University of London - Queen Mary and Westfield College
M.A. Kraut, Johns Hopkins University
L. Daraz, Mayo Clinic, Rochester, MN
F.J. Kirkham, University of Southampton
M.H. Murad, Mayo Clinic, Rochester, MN

Journal

Blood Advances

Publication Date

2020

Volume

4

Issue

8

First Page

1554

Last Page

1588

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2019001142

Rights and Permissions

M. R. DeBaun, L. C. Jordan, A. A. King, J. Schatz, E. Vichinsky, C. K. Fox, R. C. McKinstry, P. Telfer, M. A. Kraut, L. Daraz, F. J. Kirkham, M. H. Murad; American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv 2020; 4 (8): 1554–1588. doi: https://doi.org/10.1182/bloodadvances.2019001142

Recommended Citation

DeBaun, M.R.; Jordan, L.C.; King, A.A.; Schatz, J.; Vichinsky, E.; Fox, C.K.; McKinstry, R.C.; Telfer, P.; Kraut, M.A.; Daraz, L.; Kirkham, F.J.; and Murad, M.H., "American Society of Hematology 2020 guidelines for sickle cell disease: Prevention, diagnosis, and treatment of cerebrovascular disease in children and adults." Blood Advances. 4, 8. 1554 - 1588. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9397